MARKET

RPTX

RPTX

Repare Therapeutics Inc.
NASDAQ
2.580
+0.020
+0.78%
After Hours: 2.590 +0.01 +0.39% 19:27 12/30 EST
OPEN
2.560
PREV CLOSE
2.560
HIGH
2.610
LOW
2.558
VOLUME
827.86K
TURNOVER
--
52 WEEK HIGH
2.660
52 WEEK LOW
0.8900
MARKET CAP
111.22M
P/E (TTM)
-1.5228
1D
5D
1M
3M
1Y
5Y
1D
Repare Therapeutics Sells RP-3467 Program to Gilead
TipRanks · 1d ago
XenoTherapeutics to Acquire All Outstanding Shares of Repare Therapeutics
Reuters · 2d ago
Weekly Report: what happened at RPTX last week (1222-1226)?
Weekly Report · 2d ago
Repare Sells Key Oncology Asset to Gilead, Lifts Expected Xeno Deal Payout
TipRanks · 4d ago
Wednesday Sector Leaders: Drugs, Biotechnology Stocks
NASDAQ · 6d ago
Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million
Benzinga · 6d ago
Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead
Dow Jones · 6d ago
Market-Moving News for December 24th
Benzinga · 12/24 12:20
More
About RPTX
Repare Therapeutics Inc. is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.

Webull offers Repare Therapeutics Inc stock information, including NASDAQ: RPTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RPTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RPTX stock methods without spending real money on the virtual paper trading platform.